Ocuphire Pharma Investor Day Presentation Deck slide image

Ocuphire Pharma Investor Day Presentation Deck

110 Ocuphire Board of Directors Seasoned Directors with Decades of Drug Development, M&A/Financings, & Ophthalmology Cam Gallagher, MBA Chair, Board Director University of San Diego A VELOSBIO ONCTERNAL therapeutics zentalis RetroSense THERAPEUTICS Mina Sooch, MBA Vice-Chair, Board Director President & CEO HARVARD BUSINESS SCHOOL Gemphire Therapeutics MONITOR ProNAI Apjohn Ventures James Manuso, PhD/MBA Board Director Columbia Business School astex pharmaceuticals Talfinium Investments, Inc. GALENICA PARTNER IN PHARMACEUTICAL TECHNOLOGY Sean Ainsworth, MBA Lead Independent Director, Board Director Washington University in St. Louis OLIN BUSINESS SCHOOL Allergan RetroSense THERAPEUTICS Richard Rodgers, MBA Board Director CARLSON IMMUSOFT Programming Cures SCHOOL OF MANAGEMENT UNIVERSITY OF MINNESOTA TESARO™ MGI. PHARMA CA BioScience Jay Pepose, MD, PhD Board Director SOLO UCLA Théa let's open our eyes PeposeVision INSTITUTE Wilmer Eye Institute David Geffen School of Medicine Washington University in St. Louis Susan Benton, MBA Board Director USF MUMA COLLEGE OF BUSINESS UNIVERSITY OF SOUTH FLORIDA BAUSCH + LOMB Shire Ocuphire PHARMA
View entire presentation